Person:
McGovern, Kelly

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

McGovern

First Name

Kelly

Name

McGovern, Kelly

Filters

20191

Settings

Author's Publications: search.filters.isAuthorOfPublication.5058d0f1-b674-4509-923a-4044b55a1361

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Publication
    Targeted Selection of HIV-Specific Antibody Mutations by Engineering B Cell Maturation
    (American Association for the Advancement of Science, 2019-12-06) Saunders, Kevin O.; Wiehe, Kevin; Tian, Ming; Acharya, Priyamvada; Bradley, Todd; Alam, S. Munir; Go, Eden P.; Scearce, Richard; Sutherland, Laura; Henderson, Rory; Hsu, Allen; Borgnia, Mario; Chen, Haiyan; Lu, Xiaozhi; Wu, Nelson R.; Watts, Brian; Jiang, Chuancang; Easterhoff, David; Cheng, Hwei-Ling; McGovern, Kelly; Waddicor, Peyton; Chapdelaine-Williams, Aimee M.; Eaton, Amanda; Zhang, Jinsong; Rountree, Wes; Verkoczy, Laurent; Tomai, Mark; Lewis, Mark G.; Reed, Steven G.; Desaire, Heather R.; Edwards, Robert J.; Cain, Derek W.; Bonsignori, Mattia; Montefiori, David; Alt, Frederick; Haynes, Barton F.; Haynes, Barton
    Engineering the immune system by design of immunogens to direct antibody maturation is a major goal of vaccinologists. One of the roadblocks preventing HIV vaccine development is the requirement for broadly neutralizing antibodies (bnAbs) to acquire somatic mutations rarely made by activation-induced cytidine deaminase. Here, we designed immunogens that bind with higher affinity to antibodies with improbable mutations than to unmutated precursor antibodies. We demonstrated for two bnAb B cell lineages using knockin mouse models that such immunogens engaged unmutated bnAb precursors, selected for functional improbable mutations, and induced neutralizing antibodies. Structural studies revealed how bnAb precursors interacted with Env and revealed the functions of the elicited improbable mutations. In primates, the CD4 binding site-targeting immunogen induced potent CD4 binding site neutralizing antibodies in macaques. This immunogen design strategy will allow for the delineation of sequential immunogens to direct bnAb development for HIV-1 and other pathogens.